Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Leases (2019 - 2025)

Historic Current Leases for Collegium Pharmaceutical (COLL) over the last 7 years, with Q3 2025 value amounting to $1.4 million.

  • Collegium Pharmaceutical's Current Leases rose 794.65% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 794.65%. This contributed to the annual value of $1.3 million for FY2024, which is 2864.37% up from last year.
  • Collegium Pharmaceutical's Current Leases amounted to $1.4 million in Q3 2025, which was up 794.65% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Current Leases ranged from a high of $1.4 million in Q3 2025 and a low of $750000.0 during Q1 2021
  • In the last 5 years, Collegium Pharmaceutical's Current Leases had a median value of $1.0 million in 2023 and averaged $1.1 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Current Leases soared by 5706.87% in 2022 and then crashed by 1981.83% in 2023.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Current Leases stood at $814000.0 in 2021, then surged by 36.61% to $1.1 million in 2022, then decreased by 11.15% to $988000.0 in 2023, then increased by 28.64% to $1.3 million in 2024, then increased by 7.95% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.3 million for Q2 2025, and $1.3 million during Q1 2025.